EP3143494A4 - Systeme und verfahren zur verwaltung der behandlung eines chronischen zustandes durch symptomverfolgung - Google Patents

Systeme und verfahren zur verwaltung der behandlung eines chronischen zustandes durch symptomverfolgung Download PDF

Info

Publication number
EP3143494A4
EP3143494A4 EP15793415.9A EP15793415A EP3143494A4 EP 3143494 A4 EP3143494 A4 EP 3143494A4 EP 15793415 A EP15793415 A EP 15793415A EP 3143494 A4 EP3143494 A4 EP 3143494A4
Authority
EP
European Patent Office
Prior art keywords
systems
methods
chronic condition
managing treatment
symptom tracking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP15793415.9A
Other languages
English (en)
French (fr)
Other versions
EP3143494A2 (de
EP3143494B1 (de
Inventor
Steven Lo
David PENAKE
John Lyons
Lisa SAGINIAN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corcept Therapeutics Inc
Original Assignee
Corcept Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corcept Therapeutics Inc filed Critical Corcept Therapeutics Inc
Publication of EP3143494A2 publication Critical patent/EP3143494A2/de
Publication of EP3143494A4 publication Critical patent/EP3143494A4/de
Application granted granted Critical
Publication of EP3143494B1 publication Critical patent/EP3143494B1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16Z—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS, NOT OTHERWISE PROVIDED FOR
    • G16Z99/00—Subject matter not provided for in other main groups of this subclass
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00—ICT specially adapted for the handling or processing of medical images
    • G16H30/40—ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/103—Measuring devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
    • A61B5/107—Measuring physical dimensions, e.g. size of the entire body or parts thereof
    • A61B5/1079—Measuring physical dimensions, e.g. size of the entire body or parts thereof using optical or photographic means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/492—Determining multiple analytes
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/60—Analysis of geometric attributes
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V40/00—Recognition of biometric, human-related or animal-related patterns in image or video data
    • G06V40/10—Human or animal bodies, e.g. vehicle occupants or pedestrians; Body parts, e.g. hands
    • G06V40/16—Human faces, e.g. facial parts, sketches or expressions
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Chemical & Material Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Ecology (AREA)
  • Biochemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Geometry (AREA)
  • Multimedia (AREA)
  • Human Computer Interaction (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Dentistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
EP15793415.9A 2014-05-16 2015-05-18 Systeme und methoden zur verwaltung der behandlung des cushing-syndroms durch symptomverfolgung Active EP3143494B1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461994815P 2014-05-16 2014-05-16
PCT/US2015/031408 WO2015176062A2 (en) 2014-05-16 2015-05-18 Systems and methods of managing treatment of a chronic condition by symptom tracking

Publications (3)

Publication Number Publication Date
EP3143494A2 EP3143494A2 (de) 2017-03-22
EP3143494A4 true EP3143494A4 (de) 2018-01-24
EP3143494B1 EP3143494B1 (de) 2021-03-31

Family

ID=54480946

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15793415.9A Active EP3143494B1 (de) 2014-05-16 2015-05-18 Systeme und methoden zur verwaltung der behandlung des cushing-syndroms durch symptomverfolgung

Country Status (8)

Country Link
US (2) US9977875B2 (de)
EP (1) EP3143494B1 (de)
JP (2) JP6712233B2 (de)
CN (1) CN106662992A (de)
AU (1) AU2015258807B2 (de)
CA (1) CA2948575C (de)
ES (1) ES2871089T3 (de)
WO (1) WO2015176062A2 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3143494B1 (de) 2014-05-16 2021-03-31 Corcept Therapeutics Incorporated Systeme und methoden zur verwaltung der behandlung des cushing-syndroms durch symptomverfolgung
US11045134B2 (en) * 2016-01-19 2021-06-29 Washington University Depression brain computer interface for the quantitative assessment of mood state and for biofeedback for mood alteration
US12342240B2 (en) 2016-12-15 2025-06-24 Conquer Your Addiction Llc Systems and methods for monitoring for and lowering the risk of addiction-related or restriction violation-related behavior(s)
US11636941B2 (en) 2016-12-15 2023-04-25 Conquer Your Addiction Llc Dynamic and adaptive systems and methods for rewarding and/or disincentivizing behaviors
US11412353B2 (en) 2016-12-15 2022-08-09 Conquer Your Addiction Llc Systems and methods for monitoring for and preempting the risk of a future occurrence of a quarantine violation
US10555112B2 (en) 2016-12-15 2020-02-04 David H. Williams Systems and methods for providing location-based security and/or privacy for restricting user access
US12096308B2 (en) 2016-12-15 2024-09-17 Conquer Your Addiction Llc Systems and methods for conducting/defending digital warfare or conflict
US10853897B2 (en) 2016-12-15 2020-12-01 David H. Williams Systems and methods for developing, monitoring, and enforcing agreements, understandings, and/or contracts
US12470894B2 (en) 2016-12-15 2025-11-11 Conquer Your Addiction Llc Systems and methods for proactively preempting/mitigating anxiety-related behaviors and associated issues/events
US10497242B2 (en) 2016-12-15 2019-12-03 David H. Williams Systems and methods for monitoring for and preempting pre-identified restriction violation-related behavior(s) of persons under restriction
US10621414B2 (en) * 2018-02-19 2020-04-14 Howard Jason Harrison Methods and systems for image collection and dimensional analysis for medical diagnoses
JP7230409B2 (ja) * 2018-10-02 2023-03-01 カシオ計算機株式会社 判定装置、判定方法及び判定プログラム
US11728031B2 (en) 2018-10-12 2023-08-15 Bfc Med Llc Software application for patient care and related device, system, and method
CN110473629A (zh) * 2019-08-22 2019-11-19 南京航空航天大学 一种肾透析治疗方案推荐方法及系统
JP7419720B2 (ja) * 2019-09-24 2024-01-23 カシオ計算機株式会社 画像処理装置、画像処理方法及び画像処理プログラム
CN111493585A (zh) * 2020-04-24 2020-08-07 王晨庄 基于5g智能化的多用途综合远控床医疗体和智能方法
US11504048B2 (en) 2020-06-10 2022-11-22 Medtronic Monitoring, Inc. Triggering arrhythmia episodes for heart failure and chronotropic incompetence diagnosis and monitoring
JP2023538014A (ja) * 2020-08-14 2023-09-06 サノフイ 監視システム
CN112489746B (zh) * 2020-12-08 2024-07-05 深圳平安智慧医健科技有限公司 数据管理的任务推送方法、装置、电子设备及存储介质
KR102510347B1 (ko) * 2021-02-10 2023-03-20 고려대학교 산학협력단 위암 수술 이후 제2형 당뇨병 예후의 예측 방법
US12009103B1 (en) * 2021-03-04 2024-06-11 Edward R Silansky Systems, devices, and/or methods for managing health
JP7135146B1 (ja) * 2021-03-26 2022-09-12 エヌ・ティ・ティ・コミュニケーションズ株式会社 投薬対象者管理システム、管理方法、管理制御装置、端末装置およびプログラム
WO2023027853A1 (en) * 2021-08-26 2023-03-02 Hypatia Group, Inc. Health monitoring system with precision eye-blocking filter
US20230381527A1 (en) * 2022-05-31 2023-11-30 West Affum Holdings Dublin DAC Wearable medical system with device parameters and patient information programmable via browser interface
CN117809857B (zh) * 2024-02-29 2024-06-07 广州市品众电子科技有限公司 一种基于人工智能的vr设备运行数据分析方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103690149A (zh) * 2013-12-30 2014-04-02 惠州Tcl移动通信有限公司 通过面部拍照识别身体健康状况的移动终端及其实现方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008210399A (ja) * 1997-03-14 2008-09-11 First Opinion Corp 疾患管理システム
JP2004065822A (ja) 2002-08-09 2004-03-04 Nippon Colin Co Ltd 遠隔診断システム
US20050283385A1 (en) 2004-06-21 2005-12-22 The Permanente Medical Group, Inc. Individualized healthcare management system
US20060036619A1 (en) * 2004-08-09 2006-02-16 Oren Fuerst Method for accessing and analyzing medically related information from multiple sources collected into one or more databases for deriving illness probability and/or for generating alerts for the detection of emergency events relating to disease management including HIV and SARS, and for syndromic surveillance of infectious disease and for predicting risk of adverse events to one or more drugs
US20080242977A1 (en) * 2007-03-30 2008-10-02 General Electric Company Systems, methods and apparatus for longitudinal/temporal analysis of plaque lesions
US10776453B2 (en) * 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US9216221B2 (en) * 2008-11-07 2015-12-22 University Of Sheffield Medicament and method of diagnosis for treating subclinical Cushing's syndrome
WO2012093363A2 (en) 2011-01-07 2012-07-12 Koninklijke Philips Electronics N.V. Integrated access to and interation with multiplicity of clinica data analytic modules
CN102063579A (zh) * 2011-01-30 2011-05-18 潘亚萍 牙周电子病历系统及其操作方法
CN102231172A (zh) * 2011-06-10 2011-11-02 王坦 一种远程医疗信息采集系统
US20130006793A1 (en) * 2011-06-29 2013-01-03 International Business Machines Corporation Migrating Computing Environment Entitlement Contracts Based on Seller and Buyer Specified Criteria
US10500216B2 (en) 2011-11-18 2019-12-10 Corcept Therapeutics, Inc. Optimizing mifepristone absorption
EP2884888A4 (de) * 2012-08-16 2016-04-20 Ginger Io Inc Verfahren zur modellierung von verhaltens- und gesundheitsveränderungen
CN103324853A (zh) * 2013-06-25 2013-09-25 上海交通大学 基于医学图像特征的相似度计算系统及方法
CN105981017B (zh) 2013-09-20 2019-04-05 科赛普特治疗学股份有限公司 使用介入和任务分配确定的治疗的系统和方法
EP3143494B1 (de) 2014-05-16 2021-03-31 Corcept Therapeutics Incorporated Systeme und methoden zur verwaltung der behandlung des cushing-syndroms durch symptomverfolgung

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103690149A (zh) * 2013-12-30 2014-04-02 惠州Tcl移动通信有限公司 通过面部拍照识别身体健康状况的移动终端及其实现方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
STEFAN BOEHRINGER ET AL: "Automated syndrome detection in a set of clinical facial photographs", AMERICAN JOURNAL OF MEDICAL GENETICS PART A, vol. 155, no. 9, 3 August 2011 (2011-08-03), US, pages 2161 - 2169, XP055434116, ISSN: 1552-4825, DOI: 10.1002/ajmg.a.34157 *

Also Published As

Publication number Publication date
ES2871089T3 (es) 2021-10-28
US11610666B2 (en) 2023-03-21
JP2020023573A (ja) 2020-02-13
AU2015258807A1 (en) 2016-11-24
WO2015176062A3 (en) 2015-12-30
US20180240544A1 (en) 2018-08-23
CA2948575A1 (en) 2015-11-19
US9977875B2 (en) 2018-05-22
EP3143494A2 (de) 2017-03-22
WO2015176062A2 (en) 2015-11-19
CA2948575C (en) 2023-08-08
US20150332020A1 (en) 2015-11-19
AU2015258807B2 (en) 2018-11-29
CN106662992A (zh) 2017-05-10
EP3143494B1 (de) 2021-03-31
JP6712233B2 (ja) 2020-06-17
JP2017518283A (ja) 2017-07-06

Similar Documents

Publication Publication Date Title
EP3143494A4 (de) Systeme und verfahren zur verwaltung der behandlung eines chronischen zustandes durch symptomverfolgung
EP3138231B8 (de) Sichere computersysteme und verfahren
EP3185772A4 (de) Systeme und verfahren für phlebotomie durch einen peripheren peripheren intravenösen katheter
EP3218736A4 (de) Positionsverfolgungssysteme und -verfahren
EP3122250A4 (de) Systeme, vorrichtungen und verfahren zur verfolgung der abdominalen ausrichtung und aktivität
EP3113681A4 (de) Systeme und verfahren zur überwachung der position eines patienten
EP3060966A4 (de) Systeme und verfahren zur zielverfolgung
EP3131596A4 (de) Verfahren und systeme zur steuerung einer blutpumpe
EP3169260A4 (de) Verfahren und systeme zur behandlung von diabetes und zugehöriger erkrankungen und störungen
EP3229694A4 (de) Systeme und verfahren zur identifizierung der bewegung eines subjekts
EP3179958A4 (de) Systeme und verfahren zur kopplung und entkopplung eines katheter
EP3212270A4 (de) Kathetersystem
EP3092286A4 (de) Ethylen-zu-flüssigkeiten-systeme und -verfahren
EP3131598A4 (de) Verfahren und systeme zur aufrüstung von ventrikulären unterstützungsvorrichtungen
EP3194908A4 (de) Überwachungssysteme und -verfahren
EP3170160A4 (de) System und verfahren für intelligente alarmierung
EP3172591A4 (de) Systeme und techniken zur steuerung auf basis von geofence-überquerung
EP3107642A4 (de) Systeme und verfahren zur behandlung von blut
EP3195222A4 (de) Verfahren und systeme für elektronische transaktionen
EP3092488A4 (de) Verfahren und systeme zur bestimmung des risikos auf herzinsuffizienz
EP3125782A4 (de) Verankerungsmechanismus und systeme für endoluminale vorrichtungen
EP3238166A4 (de) Systeme und verfahren zur verbrauchsüberwachung
EP3092556A4 (de) Systeme und verfahren zum ausfallsicheren betrieb von speichervorrichtungen
EP3180764A4 (de) Ausfallsicheres elektronisches restaurantmanagementsystem
EP3227715B8 (de) Verfahren und systeme zur positionsverfolgung

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20161206

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20180102

RIC1 Information provided on ipc code assigned before grant

Ipc: G06Q 50/24 00000000ALI20171219BHEP

Ipc: G06F 17/40 20060101ALI20171219BHEP

Ipc: A61K 31/567 20060101ALI20171219BHEP

Ipc: G06F 19/00 20180101ALI20171219BHEP

Ipc: G06F 7/06 20060101AFI20171219BHEP

Ipc: G06G 7/60 20060101ALI20171219BHEP

Ipc: G01N 33/49 20060101ALI20171219BHEP

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1235498

Country of ref document: HK

RIC1 Information provided on ipc code assigned before grant

Ipc: G06F 19/00 20180101ALI20171219BHEP

Ipc: G01N 33/49 20060101ALI20171219BHEP

Ipc: G06G 7/60 20060101ALI20171219BHEP

Ipc: G06F 7/06 20060101AFI20171219BHEP

Ipc: G06Q 50/24 20120101ALI20171219BHEP

Ipc: A61K 31/567 20060101ALI20171219BHEP

Ipc: G06F 17/40 20060101ALI20171219BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CORCEPT THERAPEUTICS INCORPORATED

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: CORCEPT THERAPEUTICS INCORPORATED

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20191108

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Ref document number: 602015067517

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: G06F0007060000

Ipc: G16H0050200000

RIC1 Information provided on ipc code assigned before grant

Ipc: G16H 50/20 20180101AFI20200930BHEP

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20210113

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1377854

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210415

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602015067517

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210630

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20210331

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1377854

Country of ref document: AT

Kind code of ref document: T

Effective date: 20210331

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2871089

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20211028

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210802

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210731

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602015067517

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210531

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210531

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20210531

26N No opposition filed

Effective date: 20220104

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210518

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210731

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210531

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: MC

Payment date: 20230330

Year of fee payment: 9

Ref country code: FR

Payment date: 20230309

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20150518

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230330

Year of fee payment: 9

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230404

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 20230512

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20230412

Year of fee payment: 9

Ref country code: ES

Payment date: 20230605

Year of fee payment: 9

Ref country code: DE

Payment date: 20230321

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 602015067517

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240518

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20240518

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240531

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240518

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20241203

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240518

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240518

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20250630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20240519

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210331